Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.57%
#2 Palladium Network Palladium Network +6.43%
#3 Cryptopia Cryptopia +4.36%
#4 SIXSEVEN SIXSEVEN +4.11%
#5 Kinetiq Kinetiq +3.41%
#6 Test Test +3.32%
#7 Movement Movement +3.31%
#8 Victoria VR Victoria VR +3.17%
#9 Jito Jito +3.05%
#10 COTI COTI +3.02%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Nanomix Corporation Nanomix Corporation

Nanomix Corporation

NNMX
Classifica tra le azioni #41810
Boston Therapeutics, Inc. focuses on the discovery, production, and... Boston Therapeutics, Inc. focuses on the discovery, production, and commercialization of therapeutic drugs aimed at fulfilling critical unmet medical needs in the areas of diabetes and inflammatory diseases. The company's pipeline features BTI-320, a non-systemic, carbohydrate-based tablet currently in Phase II clinical trials, which is being developed to reduce post-meal blood glucose levels in patients with pre-diabetes and type 2 diabetes. They also have IPOXYN, an injectable medication designed to prevent tissue necrosis and address conditions caused by low oxygen, such as diabetic foot ulcers and other related vascular or neurological complications. Additionally, Boston Therapeutics is progressing with BTI-410, a peptide injectable compound also in Phase II clinical development, intended to stimulate beta cell maturation in the pancreas. This could potentially serve as a new insulin-producing cell agent for individuals with type 2 diabetes and type 1 patients on immunosuppression therapy following a kidney transplant. Complementing its pharmaceutical endeavors, the company offers SUGARDOWN, a non-systemic, polysaccharide-based dietary supplement designed to support healthy blood glucose management, and OXYFEX, a veterinary application that acts as an oxygen delivery agent, similar to a red blood cell replacement, for treating ischemia, trauma, and blood loss during surgical procedures. The firm further extends its offerings to include Automatic Retinal Image Analysis (ARIA), a diagnostic tool used for screening cardiovascular risks, including stroke. Boston Therapeutics, Inc. maintains its headquarters in Lawrence, Massachusetts.
Prezzo delle azioni
$0.0002
Ultima sincronizzazione: 2025-04-08
Capitalizzazione di mercato
$9.80K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Nanomix Corporation (NNMX)

Categoria

Healthcare
Il prezzo NNMX con la capitalizzazione del mercato della B
Nanomix Corporation Nanomix Corporation
NNMX
$0.0002
Capitalizzazione di mercato di Nanomix Corporation(NNMX)
Capitalizzazione di mercato: $9.80K
A partire dal August 2026, Nanomix Corporation ha una capitalizzazione di mercato pari a $9.80K. Questo rende Nanomix Corporation la 41810th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Nanomix Corporation dal 2021 al 2026
NNMX in paragone con la classifica dei più popolari stocks
Il prezzo per NNMX Attivo B Capitalizzazione del mercato a B Risultati
Nanomix Corporation Nanomix Corporation
$109,876 $9.80K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +54,937,845,190.34%
Nanomix Corporation Nanomix Corporation
$90,282.50 $9.80K
Apple Inc. Apple Inc.
AAPL
$4.423T +45,141,251,086.22%
Nanomix Corporation Nanomix Corporation
$84,914.16 $9.80K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +42,457,081,225.46%
Nanomix Corporation Nanomix Corporation
$74,769.28 $9.80K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +37,384,639,526.49%
Nanomix Corporation Nanomix Corporation
$59,010.69 $9.80K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +29,505,345,296.47%